Single‐agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas
Elpiner A, Brodsky E, Hazzah T, Post G. Single‐agent gemcitabine chemotherapy in dogs with hepatocellular carcinomas. Veterinary And Comparative Oncology 2011, 9: 260-268. PMID: 22077406, DOI: 10.1111/j.1476-5829.2011.00262.x.Peer-Reviewed Original ResearchConceptsHepatocellular carcinomaGemcitabine chemotherapyMedian progression-free intervalSingle-agent gemcitabine chemotherapyGrade III neutropeniaNonresectable hepatocellular carcinomaSerial abdominal ultrasoundsTolerability of gemcitabineProgression-free intervalMedian survival timeAbdominal ultrasoundIncomplete resectionFree intervalSurvival timeDogsBest treatmentChemotherapyGemcitabineCarcinomaToxicityDaysVomitingNeutropeniaTolerabilityResection